Semba’s SMBC System Attacks the Bottleneck Created by Upstream Protein Increases The number of protein-based pharmaceuticals reaching the marketplace has dramatically increased over the past few years ...
Downstream bioprocessing steps have long been a challenge to drug manufacturers, particularly the chromatography step for purification of monoclonal antibodies (mAbs). The complexity of traditional ...